Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Anders E Berglund"'
Autor:
Olya Grove, Anders E Berglund, Matthew B Schabath, Hugo J W L Aerts, Andre Dekker, Hua Wang, Emmanuel Rios Velazquez, Philippe Lambin, Yuhua Gu, Yoganand Balagurunathan, Edward Eikman, Robert A Gatenby, Steven Eschrich, Robert J Gillies
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0248541 (2021)
[This corrects the article DOI: 10.1371/journal.pone.0118261.].
Externí odkaz:
https://doaj.org/article/92f46502f45b4738906c8ef62e7d448b
Autor:
Olya Grove, Anders E Berglund, Matthew B Schabath, Hugo J W L Aerts, Andre Dekker, Hua Wang, Emmanuel Rios Velazquez, Philippe Lambin, Yuhua Gu, Yoganand Balagurunathan, Edward Eikman, Robert A Gatenby, Steven Eschrich, Robert J Gillies
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0118261 (2015)
Two CT features were developed to quantitatively describe lung adenocarcinomas by scoring tumor shape complexity (feature 1: convexity) and intratumor density variation (feature 2: entropy ratio) in routinely obtained diagnostic CT scans. The develop
Externí odkaz:
https://doaj.org/article/13b1772cbf3a4946950996c2a1572661
Publikováno v:
Cells, Vol 13, Iss 11, p 942 (2024)
Glioblastoma (GBM) is the most common yet uniformly fatal adult brain cancer. Intra-tumoral molecular and cellular heterogeneities are major contributory factors to therapeutic refractoriness and futility in GBM. Molecular heterogeneity is represente
Externí odkaz:
https://doaj.org/article/323f63e52c5e445a91184b6a164dfa89
Autor:
Jamie K. Teer, Yonghong Zhang, Lu Chen, Eric A. Welsh, W. Douglas Cress, Steven A. Eschrich, Anders E. Berglund
Publikováno v:
Human Genomics, Vol 11, Iss 1, Pp 1-13 (2017)
Abstract Background Observations of recurrent somatic mutations in tumors have led to identification and definition of signaling and other pathways that are important for cancer progression and therapeutic targeting. As tumor cells contain both an in
Externí odkaz:
https://doaj.org/article/617587bcde17463eaf2d11a7e78d9a43
Autor:
Rebecca S. Hesterberg, Min Liu, Aya G. Elmarsafawi, John M. Koomen, Eric A. Welsh, Stephen G. Hesterberg, Sujeewa Ranatunga, Chunying Yang, Weimin Li, Harshani R. Lawrence, Paulo C. Rodriguez, Anders E. Berglund, John L. Cleveland
Publikováno v:
Cancer Immunology Research. 10:1263-1279
Chronic T-cell receptor (TCR) signaling in the tumor microenvironment is known to promote T-cell dysfunction. However, we reasoned that poorly immunogenic tumors may also compromise T cells by impairing their metabolism. To address this, we assessed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da7c83fd67d57fc72eeddf16a4647174
https://doi.org/10.1158/2326-6066.cir-21-0813
https://doi.org/10.1158/2326-6066.cir-21-0813
Autor:
Phillip M. Rappold, Lynda Vuong, Josef Leibold, Nicholas H. Chakiryan, Michael Curry, Fengshen Kuo, Erich Sabio, Hui Jiang, Briana G. Nixon, Ming Liu, Anders E. Berglund, Andrew W. Silagy, Eduardo A. Mascareno, Mahdi Golkaram, Mahtab Marker, Albert Reising, Alexander Savchenko, John Millholland, Ying-Bei Chen, Paul Russo, Jonathan Coleman, Ed Reznik, Brandon J. Manley, Irina Ostrovnaya, Vladimir Makarov, Renzo G. DiNatale, Kyle A. Blum, Xiaoxiao Ma, Diego Chowell, Ming O. Li, David B. Solit, Scott W. Lowe, Timothy A. Chan, Robert J. Motzer, Martin H. Voss, A. Ari Hakimi
Publikováno v:
Cancer Discov
It is poorly understood how the tumor immune microenvironment influences disease recurrence in localized clear-cell renal cell carcinoma (ccRCC). Here we performed whole-transcriptomic profiling of 236 tumors from patients assigned to the placebo-onl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e233562ba17f5dedab0008ff94fca247
https://doi.org/10.1158/2159-8290.cd-21-0925
https://doi.org/10.1158/2159-8290.cd-21-0925
Autor:
Shima Nakanishi, Jiannong Li, Anders E. Berglund, Youngchul Kim, Yonghong Zhang, Ling Zhang, Chunying Yang, Jinming Song, Raghavendra G. Mirmira, John L. Cleveland
Publikováno v:
Blood Cancer Discovery.
The MYC oncoprotein is activated in a broad spectrum of human malignancies and transcriptionally reprograms the genome to drive cancer cell growth. Given this, it is unclear if targeting a single effector of MYC will have therapeutic benefit. MYC act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b19180cbde16763824b217ecb6037bed
https://doi.org/10.1158/2643-3230.bcd-22-0162
https://doi.org/10.1158/2643-3230.bcd-22-0162
Autor:
John L. Cleveland, Anders E. Berglund, Paulo C. Rodriguez, Harshani R. Lawrence, Weimin Li, Chunying Yang, Sujeewa Ranatunga, Stephen G. Hesterberg, Eric A. Welsh, John M. Koomen, Aya G. Elmarsafawi, Min Liu, Rebecca S. Hesterberg
Supplementary Table from TCR-Independent Metabolic Reprogramming Precedes Lymphoma-Driven Changes in T-cell Fate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::276e8b13de577cf41feb818922be66c1
https://doi.org/10.1158/2326-6066.22545492
https://doi.org/10.1158/2326-6066.22545492
Autor:
A. Ari Hakimi, Martin H. Voss, Robert J. Motzer, Timothy A. Chan, Scott W. Lowe, David B. Solit, Ming O. Li, Diego Chowell, Xiaoxiao Ma, Kyle A. Blum, Renzo G. DiNatale, Vladimir Makarov, Irina Ostrovnaya, Brandon J. Manley, Ed Reznik, Jonathan Coleman, Paul Russo, Ying-Bei Chen, John Millholland, Alexander Savchenko, Albert Reising, Mahtab Marker, Mahdi Golkaram, Eduardo A. Mascareno, Andrew W. Silagy, Anders E. Berglund, Ming Liu, Briana G. Nixon, Hui Jiang, Erich Sabio, Fengshen Kuo, Michael Curry, Nicholas H. Chakiryan, Josef Leibold, Lynda Vuong, Phillip M. Rappold
It is poorly understood how the tumor immune microenvironment influences disease recurrence in localized clear-cell renal cell carcinoma (ccRCC). Here we performed whole-transcriptomic profiling of 236 tumors from patients assigned to the placebo-onl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af22d74b1526aba432a0f069b99d41d9
https://doi.org/10.1158/2159-8290.c.6549733.v1
https://doi.org/10.1158/2159-8290.c.6549733.v1
Autor:
A. Ari Hakimi, Martin H. Voss, Robert J. Motzer, Timothy A. Chan, Scott W. Lowe, David B. Solit, Ming O. Li, Diego Chowell, Xiaoxiao Ma, Kyle A. Blum, Renzo G. DiNatale, Vladimir Makarov, Irina Ostrovnaya, Brandon J. Manley, Ed Reznik, Jonathan Coleman, Paul Russo, Ying-Bei Chen, John Millholland, Alexander Savchenko, Albert Reising, Mahtab Marker, Mahdi Golkaram, Eduardo A. Mascareno, Andrew W. Silagy, Anders E. Berglund, Ming Liu, Briana G. Nixon, Hui Jiang, Erich Sabio, Fengshen Kuo, Michael Curry, Nicholas H. Chakiryan, Josef Leibold, Lynda Vuong, Phillip M. Rappold
Supplementary Figure from A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac1ec763b13cff9a6658602529674209
https://doi.org/10.1158/2159-8290.22541734.v1
https://doi.org/10.1158/2159-8290.22541734.v1